
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE is benefitting from an increase in annualized rep productivity and plans to continue expanding, with a successful first quarter and a partnership with SNN expected to contribute to revenue growth. The company's strong financials, including high gross margins and plans to launch a new product, indicate potential for continued growth in the future. However, risks such as competition and changes in reimbursement coverage should be monitored closely. Overall, the company's focus on efficiency and expansion make it an attractive investment opportunity.
Bears say
SI-BONE is currently facing potential tailwinds from the FY27 IPPS proposed rule, which could provide a significant boost to the company's revenue and reimbursement potential. However, the company's growth may not be sustainable in the long term due to the limited market for its products and the potential for changing regulations. Additionally, SI-BONE's current high valuation multiple may not be justified given its financial performance compared to peer companies in the orthopedic and spine sector.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares